高國慶院長'高御尊醫師'高御龍電商 高御書生化營養師[收集資訊交流站]美兆醫療專家

著作

Chen JS, Hsu C, Chiang NJ, Tsai CS, Tsou HH, Huang SF, Bai LY, Chang IC, Shiah HS, Ho CL, Yen CJ, Lee KD, Chiu CF, Rau KM, Yu MS, Yang Y, Hsieh RK, Chang JY, Shan YS, Chao Y, Chen LT. A KRAS Mutation Status-Stratified Randomized Phase II Trial of Gemcitabine and Oxaliplatin Alone or in Combination with Cetuximab in Advanced Biliary Tract Cancer. Ann Oncol 2015; 26(5): 943-9.

Lan YT, Huang KH, Liu CA, Tai LC, Chen MH, Chao Y, Li AF, Chiou SH, Shyr YM, Wu CW, Fang WL*. A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan. PLoS One 2015 7; 10: e0139748.

Chen YY, Li AF, Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Wu CW, Shyr YM, Fang WL. Adenosquamous Carcinoma of the Stomach and Review of the Literature. Pathol Oncol Res 2015; 21: 547-51.

Lee IC, Chen YT, Chao Y, Huo TI, Li CP, Su CW, Lin HC, Lee FY, Huang YH. Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice. Medicine (Baltimore) 2015; 94(14): -.

Wang JP, Wu CY, Yeh YC, Shyr YM, Wu YY, Kuo CY, Hung YP, Chen MH, Lee WP, Luo JC, Chao Y, Li CP. Erlotinib is Effective in Pancreatic Cancer with Epidermal Growth Factor Receptor Mutations: A Randomized, Open-Label, Prospective Trial. Oncotarget 2015; 6(20): 18162-73.

Chen SC, Chen MH, Li CP, Chen MH, Chang PM, Liu CY, Tzeng CH, Liu YM, Yen SH, Chao Y, Huang PI. External Beam Radiation Therapy with or without Concurrent Chemotherapy for Patients with Unresectable Locally Advanced Hilar Cholangiocarcinoma. Hepato-Gastroenterol 2015; 62(137): 102-7.

Chen MH, Kuo YJ, Yeh YC, Lin YC, Tzeng CH, Liu CY, Chang PM, Chen MH, Jeng YM, Chao Y. High Neuroendocrine Component is a Factor for Poor Prognosis in Gastrointestinal High-Grade Malignant Mixed Adenoneuroendocrine Neoplasms. J Chin Med Assoc 2015; 78(8): 454-9.

Chen MH, Yen CC, Cheng CT, Wu RC, Huang SC, Yu CS, Chung YH, Liu CY, Chang PM, Chao Y, Chen MH, Chen YF, Chiang KC, Yeh TS, Chen TC, Huang CY*, Yeh CN*. Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma. Oncotarget 2015; 6(27): 23594-608.

Fang WL, Hung YP, Liu CJ*, Lan YT, Huang KH, Chen MH, Lo SS, Shyr YM, Wu CW, Yang MH, Chen TJ, Chao Y*. Incidence of and Risk Factors for Tuberculosis (TB) in Gastric Cancer Patients in an Area Endemic for TB: A Nation-Wide Population-Based Matched Cohort Study. Medicine (Baltimore) 2015; 94(47): e2163.

Wang JP, Kao FY, Wu CY, Hung YP, Chao Y, Chou YJ, Li CP. Nucleos(t)ide Analogues Associated With a Reduced Risk of Hepatocellular Carcinoma in Hepatitis B Patients: A Population-Based Cohort Study. Cancer 2015; 121(9): 1446-55.

Kao WY, Chao Y, Chang CC, Li CP, Su CW, Huo TI, Huang YH, Chang YJ, Lin HC, Wu JC. Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients. Medicine (Baltimore) 2015; 94(43): -.

Teng CJ, Huon LK, Hu YW, Yeh CM, Chao Y, Yang MH, Chen TJ, Hung YP, Liu CJ*. Secondary Primary Malignancy Risk in Patients with Cervical Cancer in Taiwan: A Nation-Wide Population-Based Study. Medicine (Baltimore) 2015; 94(43): e1803.

Hung YP, Liu CJ, Hu YW, Chen MH, Li CP, Yeh CM, Chiou TJ, Chen TJ, Yang MH, Chao Y*. Secondary Primary Malignancy Risk in Patients with Ovarian Cancer in Taiwan: A Nation-Wide Population-Based Study. Medicine (Baltimore) 2015; 94(38): e1626.

Ye BW, Lee KC, Hsieh YC, Li CP, Chao Y, Hou MC, Lin HC. Self-Expandable Metallic Stent Placement in Malignant Gastric Outlet Obstruction: A Comparison Between 2 Brands of Stents. Medicine (Baltimore) 2015; 94(29): -.

Chao Y, Chung YH, Han G, Yoon JH, Yang J, Wang J, Shao GL, Kim BI, Lee TY. The Combination of Transcatheter Arterial Chemoembolization and Sorafenib is Well Tolerated and Effective in Asian Patients with Hepatocellular Carcinoma: Final Results of the START Trial. Int J Cancer 2015; 136(6): 1458-67.

Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Li AF, Wu CW, Chiou SH, Yang MH, Shyr YM, Fang WL*. The Correlation Between RhoA Expression and Clinicopathological Characteristics in Gastric Cancer Patients After Curative Surgery. World J Surg 2015; 39: 2289-99.

Tseng CL, Lai WJ, Huang CJ, Huang YH, Su CW, Lee IC, Tseng HS, Li CP, Lee RC, Lin HC, Chao Y. The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan. Medicine (Baltimore) 2015; 94(47): -.

Fang WL*, Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Wu CW, Shyr YM, Li AF*. The Risk Factors of Lymph Node Metastasis in Early Gastric Cancer. Pathol Oncol Res 2015; 21: 941-6.

Chen MH, Lin J, Hsiao CF, Shan YS, Chen YC, Chen LT, Liu TW, Li CP, Chao Y.  A Phase II Study Of Sequential Capecitabine Plus Oxaliplatin Followed By Docetaxel Plus Capecitabine In Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial. Medicine (Baltimore) 2016 Jan; 95(3): e2565.

Lee WP, Lan KH, Li CP, Chao Y, Lin HC, Lee SD.  Akt Phosphorylates Myc-Associated Zinc Finger Protein (MAZ), Releases P-MAZ From The P53 Promoter, And Activates P53 Transcription. Cancer Lett 2016 May; 375(1): 9-19.

Fang WL, Lan YT, Huang KH, Liu CA, Hung YP, Lin CH, Jhang FY, Chang SC, Chen MH, Chao Y, Lin WC, Lo SS, Fen-Yau Li A, Wu CW, Chiou SH, Shyr YM.  Clinical Significance Of Circulating Plasma DNA In Gastric Cancer. Int J Cancer 2016 Jun; 138(12): 2974-83.

Chiang NJ, Hsu C, Chen JS, Tsou HH, Shen YY, Chao Y, Chen MH, Yeh TS, Shan YS, Huang SF, Chen LT.  Expression Levels Of ROS1/ALK/c-MET And Therapeutic Efficacy Of Cetuximab Plus Chemotherapy In Advanced Biliary Tract Cancer. Sci Rep 2016 May; 6: 25369.

Fang WL, Huang KH, Lan YT, Lin CH, Chang SC, Chen MH, Chao Y, Lin WC, Lo SS, Li AF, Wu CW, Chiou SH, Shyr YM.  Mutations In PI3K/AKT Pathway Genes And Amplifications Of PIK3CA Are Associated With Patterns Of Recurrence In Gastric Cancers. Oncotarget 2016 Feb; 7(5): 6201-20.

Lee WP, Lan KH, Li CP, Chao Y, Lin HC, Lee SD.  Oncogenic Circuit Constituted By Ser31-HBx And Akt Increases Risks Of Chronic Hepatitis And Hepatocellular Carcinoma. Biochim Biophys Acta 2016 Apr; 1862(4): 837-49.

Cheng AL, Thongprasert S, Lim HY, Sukeepaisarnjaroen W, Yang TS, Wu CC, Chao Y, Chan SL, Kudo M, Ikeda M, Kang YK, Pan H, Numata K, Han G, Balsara B, Zhang Y, Rodriguez AM, Zhang Y, Wang Y, Poon RT.  Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib VS Sorafenib In Patients With Advanced Hepatocellular Carcinoma. Hepatology 2016 Apr; : .

Muro K, Oh SC, Shimada Y, Lee KW, Yen CJ, Chao Y, Cho JY, Cheng R, Carlesi R, Chandrawansa K, Orlando M, Ohtsu A.  Subgroup Analysis Of East Asians In RAINBOW: A Phase 3 Trial Of Ramucirumab Plus Paclitaxel For Advanced Gastric Cancer. J Gastroenterol Hepatol 2016 Mar; 31(3): 581-9.